New drugs of 2016

Target Audience:

Pharmacists in community-based practice.

Universal program number: 0401-0000-17-001-H01-P
CE Broker tracking number: 20-566871
Activity type: Knowledge-based

Goal:

To provide pharmacists the foundational knowledge to improve patient care by implementation of new therapies from 2016.

Summary:

The pharmaceutical options available to patients continue to grow each year. The U.S. Food and Drug Administration, or FDA, approved 22 novel drugs in 2016, including approvals for new molecular entities known as NMEs or for new biologic therapeutics.1 In 2016, the number of approvals saw a significant decrease from the two previous years. In 2015, the FDA approved 45 drugs and approved 41 drugs in 2014.2 The last year that had a smaller number of NME approvals than 2016 was 2010, when only 21 drugs were approved.2

Learning objectives:

Upon completion of this program, the pharmacist should be able to:

  1. Identify pertinent new molecular and biological entities to community and ambulatory practice that entered the U.S. drug market in the past year.
  2. Describe each medication’s mechanism, appropriate dosing parameters, contraindications and potential drug interactions.
  3. Describe how new medications compare with previous agents used for the same indication.
  4. List patient-specific characteristic and monitoring parameters for each of these medications.
To obtain credit:

To complete the program and receive CPE credit, view all lesson content and complete the learning assessment by submitting answers online. A minimum test score of 70% is needed to obtain credit. After successfully completing the learning assessment, participants must complete a program evaluation and claim the available CPE credit. Participants also must verify personal information required by CPE monitor and/or CE Broker (for Florida license holders) prior to submitting CPE credit claims. Official statements of credit are available only through CPE Monitor located at NABP.net.

If you have a question, visit our Frequently Asked Questions page.

All other customer service questions should be directed to DRSNCE@lf1925.com.

Accreditation:

Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for pharmacists and is worth 2.0 contact hours (0.2 CEUs). The activity is available for CE credit through Feb. 28, 2020.

Course summary
Credit hours: 
  • 2.00 Pharmacist
Course opens: 
02/28/2017
Course format: 
Written Lesson
Course expires: 
02/28/2020
Cost:
$17.99

Clark Kebodeaux, PharmD, BCACP, assistant professor pharmacy practice and science, University of Kentucky College of Pharmacy

Clark Kebodeaux and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.

Available Credit

  • 2.00 Pharmacist

Accreditation Period

Course opens: 
02/28/2017
Course expires: 
02/28/2020

Price

Cost:
$17.99
Please login or register to take this course.